Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

New levobupivacaine clinical data presented at European congress

Sep. 23, 1997

Acetylcholinesterase inhibitors under development at Astra

Sep. 23, 1997

New compounds from Knoll for CNS disorders

Sep. 23, 1997

Pfizer describes agents for dopamine system disorders

Sep. 23, 1997

Pramipexole monotherapy treats parkinsonian symptoms for up to two years

Sep. 22, 1997

Eisai presents novel potential antipsychotic agent

Sep. 22, 1997

Highly selective 5-HT1D agonists described by MS&D

Sep. 22, 1997

Taisho/Nihon Nohyaku evaluate thiazole derivatives as antipsychotics

Sep. 22, 1997

Carbachol analogue selective for m1 receptors in vivo

Sep. 22, 1997

Tachykinin antagonists prepared at Janssen

Sep. 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Science
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Asia
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...